Dr. Khalid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
23 Sunnybrook Rd
Raleigh, NC 27610Phone+1 919-350-8000Fax+1 919-350-7687
Summary
- Dr. Bilal Khalid is an assistant professor of medical oncology at Saint Louis University in Saint Louis MO. He received his medical degree from Ayub Medical College and completed internal medicine residency from the Erie County Medical Center at SUNY Buffalo. He worked at Roswell Park as faculty and assistant professor of medicine at SUNY buffalo for four years. He completed his hematology, oncology and cellular therapies training at Stephenson Cancer Center University of Oklahoma in Oklahoma City OK. He specializes in Thoracic Oncology and Head & Neck cancers. His areas of research include immunotherapies and its side effects. He also speaks multiple languages, including Urdu and Punjabi.
Education & Training
- University at BuffaloResidency, Internal Medicine, 2007 - 2010
- Ayub Medical CollegeClass of 2003
Certifications & Licensure
- MO State Medical License 2018 - 2025
- NC State Medical License 2022 - 2025
- OK State Medical License 2015 - 2019
- NY State Medical License 2011 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 27 citationsDo Proton Pump Inhibitors Modulate the Efficacy of anti-PD-1/PD-L1 Therapy? A Retrospective StudySarbajit Mukherjee, Sami Ibrahimi, Bilal Khalid, Darwin Roman, Daniel Zhao
Journal of Oncology Pharmacy Practice. 2019-04-01 - 8 citationsPeriorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy.Sofa Ghani, Omar Al-Ustwani, Bilal Khalid, Paul N. Bogner, Marcelle A. Grassi
Clinical Advances in Hematology & Oncology. 2013-10-01 - 2 citationsSwitching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell CarcinomaBilal Khalid, Sarbajit Mukherjee, Sami Ibrahimi, Trinitia Cannon, Elizabeth Gilles
American Journal of Therapeutics. 2018-05-01
Press Mentions
- HEALTH MATTERS: COVID Myths Dispelled; Lung and Colo-Rectcal Cancer ScreeningDecember 4th, 2020
Professional Memberships
- Member
- Member
- Member
Other Languages
- Urdu, Punjabi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: